Wagenknecht IP's Biotech Beach Law Group is a nationally recognized patent law firm with clients based in the US, Europe, Asia and Australia. Our success is based largely on our approach of building long term relationships with our clients to ensure we fully understand their mission, business goals and technology. We can then maintain an effective team both in the US and abroad of patent attorneys, scientific advisors and case managers that have a firm understanding of our client's direction. This allows our patent attorneys to provide the most personalized, thorough and cost effective intellectual property representation available.
Our patent and trademark law firm has a proven record of success of establishing, expanding and improving patent and trademark portfolios. We've also developed useful approaches to condensing patent and trademark families into easy to understand corporate intellectual property reports with quarterly due dates useful for a variety of executive meetings, presentations and budget committees.
In addition to preparing and prosecuting US Patents and Trademarks our firm also maintains relationships with a variety of European and Asian firms with different specialty groups (including the biosciences) to obtain our global approach of patent and trademark protection and enforcement.
Necessity is the mother of invention. We’ve found that physician’s are remarkable inventors. Their need to perform complex procedures with difficult to manipulate surgical tools, crude prostheses, and increasing time demands leads these overachievers to develop a variety of improved medical devices and treatment methods.
We find that often these medical devices and treatment methods cross multiple technologies, including the biosciences, chemstry, electronics and mechanical devices. Our patent attorneys are accustomed to bridging scientific disciplines in the development of new medical devices and treatments.
Our patent attorneys regularly act as US representatives for European corporations directly or through their European law firm. Our understanding of the differences between European and US patent application requirements allows us to quickly convert a European patent application into proper US patent format, which reduces the time to grant.
Our attorneys can cost effectively enter US National Phase from PCT patent applications, prepare US declarations and assignments, file information disclosure statements (IDS) from international search reports, and provide suggestions to traverse rejections based on US examination policies.
When working with European firms we can provide as little or as much input as desired.
Ray is a registered US patent attorney with over 10 years experience and over 100 issued patents. He is also a coauthor on a number of peer reviewed scientific papers.
Paul has been a registered patent agent since 2006 and formerly served as in-house patent manager overseeing an extensive patent estate for a San Diego biotechnology company.
Ramona brings expertise in document preparation and handling from her intellectual property paralegal experience from previous positions at many of the well known large law firms.
Erma brings administrative experience from her former positions at large investment and wealth management financial services institutions.
Provisional patent applications do not issue as patents themselves but instead are priority documents. After filing a provisional patent application the patentee has one year to file a regular nonprovisional patent application and any foriegn or international PCT patent applications.
Provisional patent applications lack many of the formal requirements of regular nonprovisional patent applications but must still comply with the written description requirement in that it must describe the invention sufficiently to demonstrate possession of the invention and must teach one skilled in the art to make and use the invention.
Contact our attorneys for more information about provisional patent applications.
Our initial patent consultation provides an overview of the different type of patents and how they can be leveraged to obtain early issue dates, and establish priority dates that do not count against the term of a later issued US patent.
US design patents differ from utility patent applications in that design patents only protect the ornamental characteristics of the invention. In other words, a design patent protects the "look" of the invention.
While utility patent applications are certainly broader than design patents, a design patent can be used to protect the appearance of the device itself. We tend to think of design patents as a way of protecting trade dress until secondary meaning can be associated with the appearance of the device.
Design patents also tend to issue much quicker and therefore may be used as a first issued patent in a patent portfolio.